Pharmacology of novel treatments for COPD: are fixed dose combination LABA/LAMA synergistic?
Author:
Affiliation:
1. Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, Pharmacology and Therapeutics, King's College London, London, UK
Publisher
Informa UK Limited
Subject
Pulmonary and Respiratory Medicine
Link
https://www.tandfonline.com/doi/pdf/10.3402/ecrj.v2.26634
Reference100 articles.
1. Rigotti NA. Smoking cessation in patients with respiratory disease: existing treatments and future directions. Lancet Respir Med. 2013; 1: 241–50.
2. Ramsey SD, Berry K, Etzioni R, Kaplan RM, Sullivan SD, Wood DE. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med. 2003; 348: 2092–102.
3. Kaplan RM, Sun Q, Naunheim KS, Ries AL. Long-term follow-up of high-risk patients in the National Emphysema Treatment Trial. Ann Thorac Surg. 2014; 98: 1782–9.
4. Kaplan RM, Sun Q, Ries AL. Quality of well-being outcomes in the national emphysema treatment trial. Chest. 2015; 147: 377–87.
5. Cazzola M, Page CP, Rogliani P, Matera MG. β2-agonist therapy in lung disease. Am J Respir Crit Care Med. 2013; 187: 690–6.
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase;Nature Communications;2023-11-14
2. Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval;Expert Opinion on Investigational Drugs;2023-06-03
3. A reappraisal of inspiratory capacity in chronic obstructive pulmonary disease: clinical correlates and role of long-acting muscarinic antagonists and long-acting β2 agonists;Expert Review of Respiratory Medicine;2022-06-03
4. Pharmaceutical application and development of fixed-dose combination: dosage form review;Journal of Pharmaceutical Investigation;2021-08-30
5. Time‐resolved proteomic profiling of cigarette smoke‐induced experimental chronic obstructive pulmonary disease;Respirology;2021-07-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3